Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hepatitis A vaccine (inactivated, adsorbed) inj 1ml pfs
140400030AAACAC
|
Hepatitis A | Hepatitis A | Immunological Products and Vaccines | 270 |
|
Hepatitis A vaccine (inactivated, adsorbed) inj 0.5ml pfs
140400030AAADAD
|
Hepatitis A | Hepatitis A | Immunological Products and Vaccines | 69 |
|
Hepatitis A vacc (inactivated, adsorbed) inj 1ml vials
140400030AAAKAK
|
Hepatitis A | Hepatitis A | Immunological Products and Vaccines | 4 |
|
Hepatitis A vacc (inactivated, adsorbed) inj 0.5ml pfs
140400030AAAIAI
|
Hepatitis A | Hepatitis A | Immunological Products and Vaccines | No data available |
|
Hepatitis A vacc (inactivated, adsorbed) inj 0.5ml vials
140400030AAAJAJ
|
Hepatitis A | Hepatitis A | Immunological Products and Vaccines | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.